GCM2 and breast cancer: Aberrant methylation patterns of the CCDC181, GCM2 and ITPRIPL1 genes are highly prevalent in Western and Taiwanese breast cancer patients, suggesting that they are potential biomarkers for early prediction in Western and Asian countries.